Le Lézard
Classified in: Health
Subject: SVY

The global cardiovascular devices market is expected to reach US$ 71.1 Bn in 2027 from US$ 40.8 Bn in 2018


NEW YORK, Jan. 21, 2020 /PRNewswire/ --

The global cardiovascular devices market is expected to reach US$ 71.1 Bn in 2027 from US$ 40.8 Bn in 2018. The cardiovascular devices market is estimated to grow with a CAGR of 6.5% from 2019-2027.

Read the full report: https://www.reportlinker.com/p05774498/?utm_source=PRN

The market is driven by the factors such as, significantly increasing prevalence of cardiovascular diseases, rising developments for cardiovascular devices, and increasing elderly population. Whereas, the market is likely to slower down its growth owing to the restraining factors such as rigorous regulations for approval and high cost of products and procedures.
The cardiovascular devices market is majorly driven by the changes or the sifting in the trend of the technology that enables the players to develop innovative devices.The shift in the technology provides an aim for the market players to improve their product.

The innovative product assists in enhancing the better results for health and live better life. The market is consolidated with various market leaders that are conducting various developmental activities for the cardiovascular devices.
For instance, mobile cardiac telemetry (MCT) system is the innovative product that is assisting the cardiac patients to monitor their heart condition.The mobile cardiac telemetry is a small sensor and monitor that patients wear in their day to day life.

Whenever cardiac events occur, MCT instantaneously transmits the data to a center for analysis and response, which in turn sends a report along with graphs and trends to the patient's physician for diagnosis and therapy management.MCT is one of the most effective methods of cardiac monitoring.

The ability to analyze every heartbeat with little interference to the patient's normal day. It also create opportunity to initiate an immediate emergency response as needed, makes it one of the most attractive choices in today's market.
Global cardiovascular devices market was segmented by device, application and end user.The device segments was classified as electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others.

Based on the application it is divided into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease and others. And on the basis of the end user the market is classified as hospitals, ambulatory surgery centers, and cardiac centers.
Some of the major primary and secondary sources included in the report for the cardiovascular devices market are World Health Organization, American College of Cardiology, American Heart Association, Dubai Health Authority, European Heart Network, Health Authority of Abu Dhabi, Italian National Health Service, Brazilian Society of Cardiology and others.

Read the full report: https://www.reportlinker.com/p05774498/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...



News published on and distributed by: